These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 16515370

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events.
    Starner CI, Schafer JA, Heaton AH, Gleason PP.
    J Manag Care Pharm; 2008; 14(6):523-31. PubMed ID: 18693776
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
    Balkrishnan R, Arondekar BV, Camacho FT, Shenolikar RA, Horblyuk R, Anderson RT.
    Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large U.S. Managed Care Population.
    Grabner M, Peng X, Geremakis C, Bae J.
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1204-12. PubMed ID: 26679969
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care costs in a Medicare Advantage Prescription Drug Plan population.
    Bergeson JG, Worley K, Louder A, Ward M, Graham J.
    J Manag Care Pharm; 2013 Jun; 19(5):374-84. PubMed ID: 23697475
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cost of self-monitoring of blood glucose in the United States among patients on an insulin regimen for diabetes.
    Yeaw J, Lee WC, Aagren M, Christensen T.
    J Manag Care Pharm; 2012 Jun; 18(1):21-32. PubMed ID: 22235952
    [Abstract] [Full Text] [Related]

  • 12. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis.
    Rajagopalan R, Rosenson RS, Fernandes AW, Khan M, Murray FT.
    Clin Ther; 2004 Sep; 26(9):1400-10. PubMed ID: 15531002
    [Abstract] [Full Text] [Related]

  • 13. Economic Impact of Treatment Duration and Persistence with Basal Insulin in Previously Insulin-Naive Users.
    Kalirai S, Duan R, Liu D, Reed BL.
    J Manag Care Spec Pharm; 2017 Mar; 23(3):327-336. PubMed ID: 28230446
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease.
    Mucha L, Shaohung S, Cuffel B, McRae T, Mark TL, Del Valle M.
    J Manag Care Pharm; 2008 Jun; 14(5):451-61. PubMed ID: 18597574
    [Abstract] [Full Text] [Related]

  • 17. Disease-related and all-cause health care costs of elderly patients with gout.
    Wu EQ, Patel PA, Yu AP, Mody RR, Cahill KE, Tang J, Krishnan E.
    J Manag Care Pharm; 2008 Mar; 14(2):164-75. PubMed ID: 18331118
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Medical utilization associated with palivizumab compliance in a commercial and managed medicaid health plan.
    Diehl JL, Daw JR, Coley KC, Rayburg R.
    J Manag Care Pharm; 2010 Mar; 16(1):23-31. PubMed ID: 20044844
    [Abstract] [Full Text] [Related]

  • 20. Administrative claims analysis of utilization and costs of care in health plan members with atopic dermatitis who had prior use of a topical corticosteroid and who initiate therapy with pimecrolimus or tacrolimus.
    Delea TE, Gokhale M, Makin C, Hussein MA, Vanderpoel J, Sandman T, Chang J, Sung J, Pinkston P, Gause D, Jackson M.
    J Manag Care Pharm; 2007 May; 13(4):349-59. PubMed ID: 17506601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.